AU2014249258A1 - Treatment of pediatric growth hormone deficiency with human growth hormone analogues - Google Patents

Treatment of pediatric growth hormone deficiency with human growth hormone analogues Download PDF

Info

Publication number
AU2014249258A1
AU2014249258A1 AU2014249258A AU2014249258A AU2014249258A1 AU 2014249258 A1 AU2014249258 A1 AU 2014249258A1 AU 2014249258 A AU2014249258 A AU 2014249258A AU 2014249258 A AU2014249258 A AU 2014249258A AU 2014249258 A1 AU2014249258 A1 AU 2014249258A1
Authority
AU
Australia
Prior art keywords
days
hgh
xten
fusion protein
bolus dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014249258A
Other languages
English (en)
Inventor
George M. Bright
Jeffrey L. Cleland
Eric HUMPHRISS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amunix Pharmaceuticals Inc
Original Assignee
Amunix Operating Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amunix Operating Inc filed Critical Amunix Operating Inc
Publication of AU2014249258A1 publication Critical patent/AU2014249258A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AU2014249258A 2013-03-11 2014-03-10 Treatment of pediatric growth hormone deficiency with human growth hormone analogues Abandoned AU2014249258A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201361776618P 2013-03-11 2013-03-11
US61/776,618 2013-03-11
US201361810786P 2013-04-11 2013-04-11
US61/810,786 2013-04-11
US201361835002P 2013-06-14 2013-06-14
US61/835,002 2013-06-14
US201361880701P 2013-09-20 2013-09-20
US61/880,701 2013-09-20
US201361911731P 2013-12-04 2013-12-04
US61/911,731 2013-12-04
US201461931987P 2014-01-27 2014-01-27
US61/931,987 2014-01-27
US201461948457P 2014-03-05 2014-03-05
US61/948,457 2014-03-05
PCT/US2014/022850 WO2014164568A1 (en) 2013-03-11 2014-03-10 Treatment of pediatric growth hormone deficiency with human growth hormone analogues

Publications (1)

Publication Number Publication Date
AU2014249258A1 true AU2014249258A1 (en) 2015-08-27

Family

ID=51658905

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014249258A Abandoned AU2014249258A1 (en) 2013-03-11 2014-03-10 Treatment of pediatric growth hormone deficiency with human growth hormone analogues

Country Status (16)

Country Link
US (1) US20160158321A1 (enrdf_load_stackoverflow)
EP (1) EP2968451A4 (enrdf_load_stackoverflow)
JP (3) JP2016514132A (enrdf_load_stackoverflow)
KR (1) KR20150124955A (enrdf_load_stackoverflow)
CN (1) CN105209055A (enrdf_load_stackoverflow)
AU (1) AU2014249258A1 (enrdf_load_stackoverflow)
BR (1) BR112015022257A8 (enrdf_load_stackoverflow)
CA (1) CA2900949A1 (enrdf_load_stackoverflow)
CL (1) CL2015002456A1 (enrdf_load_stackoverflow)
EA (1) EA201591529A1 (enrdf_load_stackoverflow)
HK (1) HK1216617A1 (enrdf_load_stackoverflow)
IL (1) IL240392A0 (enrdf_load_stackoverflow)
MX (1) MX2015012175A (enrdf_load_stackoverflow)
PH (1) PH12015502063A1 (enrdf_load_stackoverflow)
SG (1) SG11201506732YA (enrdf_load_stackoverflow)
WO (1) WO2014164568A1 (enrdf_load_stackoverflow)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
WO2016109823A1 (en) * 2015-01-02 2016-07-07 Amunix Operation Inc. Treatment of pediatric growth hormone deficiency with human growth hormone analogues
AU2016214265A1 (en) 2015-02-03 2017-08-17 Apple Inc. Family sleep monitoring system
IL319047A (en) 2015-08-28 2025-04-01 Amunix Operating Inc Chimeric polypeptide composition and methods for its preparation and use
WO2017136583A1 (en) 2016-02-02 2017-08-10 Versartis, Inc. Growth hormone treatment adherence system
CA3014164A1 (en) 2016-02-17 2017-08-24 Genexine, Inc. Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
JOP20190019A1 (ar) * 2016-08-30 2019-02-12 Genexine Inc تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH)
US10288629B1 (en) * 2017-12-19 2019-05-14 Aeterna Zentaris, Inc. Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
KR20200111176A (ko) 2017-12-21 2020-09-28 아뮤닉스 파마슈티컬스, 인크. 유리 세그먼트 및 이것을 포함하는 결합 조성물
US11903683B2 (en) 2018-08-03 2024-02-20 Chelak Medical Solutions Inc Non-barometric determination of hemodynamic effects of cardiac arrhythmias using signals sensed by an implantable device
RU2753191C2 (ru) * 2019-09-26 2021-08-12 Федеральное государственное бюджетное учреждение науки Институт Биологии Развития им. Н.К. Кольцова Российской Академии Наук Новый рекомбинантный аналог гормона роста пролонгированного действия
EP4085077A4 (en) 2019-12-31 2024-01-17 Beijing QL Biopharmaceutical Co., Ltd. FUSION PROTEINS FROM GLP-1 AND GDF15 AND CONJUGATES THEREOF
WO2021139744A1 (en) 2020-01-11 2021-07-15 Beijing Ql Biopharmaceutical Co., Ltd. Conjugates of fusion proteins of glp-1 and fgf21
KR102599111B1 (ko) * 2020-01-31 2023-11-07 울산대학교 산학협력단 인슐린유사성장인자-1 융합단백질 및 이의 용도
CN114258492A (zh) * 2020-07-22 2022-03-29 阿特纳赞塔里斯有限公司 一种通过使用马昔瑞林诊断儿科患者中生长激素缺乏症的筛选方法
JP2023545684A (ja) 2020-09-30 2023-10-31 ベイジン キューエル バイオファーマシューティカル カンパニー,リミテッド ポリペプチドコンジュゲートおよび使用の方法
CN116848243B (zh) 2022-03-30 2024-03-19 北京质肽生物医药科技有限公司 多肽缀合物的液体药物组合物和其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102348715B (zh) * 2009-02-03 2017-12-08 阿穆尼克斯运营公司 延伸重组多肽和包含该延伸重组多肽的组合物
EP2473850B1 (en) * 2009-09-02 2015-05-13 Merck Serono S.A. Method of predicting the level of growth response
SG11201408152VA (en) * 2012-06-05 2015-01-29 Amunix Operating Inc Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency

Also Published As

Publication number Publication date
BR112015022257A2 (pt) 2017-10-10
EP2968451A4 (en) 2017-01-04
KR20150124955A (ko) 2015-11-06
WO2014164568A1 (en) 2014-10-09
PH12015502063A1 (en) 2016-01-25
US20160158321A1 (en) 2016-06-09
JP2019056013A (ja) 2019-04-11
JP2017101074A (ja) 2017-06-08
HK1216617A1 (zh) 2016-11-25
EA201591529A1 (ru) 2016-04-29
SG11201506732YA (en) 2015-09-29
EP2968451A1 (en) 2016-01-20
CN105209055A (zh) 2015-12-30
IL240392A0 (en) 2015-09-24
MX2015012175A (es) 2016-01-12
CA2900949A1 (en) 2014-10-09
BR112015022257A8 (pt) 2018-01-23
JP2016514132A (ja) 2016-05-19
CL2015002456A1 (es) 2016-05-27

Similar Documents

Publication Publication Date Title
US20160158321A1 (en) Treatment of pediatric growth hormone deficiency with human growth hormone analogues
EP2858664B1 (en) Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency
RU2477286C2 (ru) АНАЛОГИ ГЛЮКАГОНА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ РАСТВОРИМОСТЬЮ В БУФЕРАХ С ФИЗИОЛОГИЧЕСКИМ ЗНАЧЕНИЕМ pH
WO2016109823A1 (en) Treatment of pediatric growth hormone deficiency with human growth hormone analogues
EP0914341B1 (en) Antagonists of intestinotrophic glp-2 peptides
US20160375101A1 (en) Methods of Using Interleukin-10 for Treating Diseases and Disorders
KR20120036947A (ko) 성장 호르몬 폴리펩타이드 및 이를 제조하고 사용하는 방법
US10010588B2 (en) Methods of using pegylated interleukin-10 for treating hyperlipidemia
Kanematsu-Yamaki et al. Potent body weight-lowering effect of a neuromedin U receptor 2-selective PEGylated peptide
TWI773009B (zh) 新穎之胰島素類似物及其用途
KR20150005904A (ko) 강력한 작용제 효과를 지닌 신규한 gh-rh 유사체
US20200000884A1 (en) Treatment of adult growth hormone deficiency with human growth hormone analogues
WO2014014819A2 (en) Methods of treating glucose metabolism disorders
WO2013151627A1 (en) Methods of treating glucose metabolism disorders

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application